SCHEMBL25376544

SCHEMBL25376544

CCOC(=O)C(=O)N(Cc1ccccc1)Cc1ccc(C)cc1C.Cc1ccc(CN(Cc2ccccc2)C(=O)C(N)=O)c(C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPM8 Q7Z2W7 1/20 0.42
▸ ALDH1A1 P00352 7/20 0.39
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ MAPT P10636 1/20 0.39
▸ TSHR P16473 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ JAK2 O60674 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ PAX8 Q06710 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ F2 P00734 3/20 0.38
▸ LMNA P02545 2/20 0.38
▸ F10 P00742 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25373947 0.94 TRPM8 (0.46) TRPM8ALDH1A1MEN1KMT2AMAPT
SCHEMBL25376252 0.91 MEN1 (0.44) TRPM8ALDH1A1MEN1KMT2AMAPT
SCHEMBL25373573 0.89 TRPM8 (0.42) TRPM8ALDH1A1MEN1KMT2AMAPT
SCHEMBL25376218 0.83 ALDH1A1 (0.42) TRPM8ALDH1A1KMT2ATSHRMAPK1
SCHEMBL25376774 0.81 TRPM8 (0.41) TRPM8ALDH1A1MEN1KMT2ATSHR
SCHEMBL25374455 0.80 TSPO (0.46) TRPM8ALDH1A1MEN1KMT2AMAPT
SCHEMBL25378150 0.80 HDAC1 (0.46) ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL25375679 0.79 EGFR (0.44) ALDH1A1TSHRMAPK1LMNAATM
SCHEMBL25376959 0.79 MEN1 (0.42) ALDH1A1MEN1KMT2ATSHRMAPK1
Ammonia Solution, Strong SCHEMBL25375174 0.78 MAPK1 (0.43) ALDH1A1MEN1KMT2ATSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4469438-A1 COMPOUNDS AND METHODS OF USE Tango Therapeutics, Inc. (US) 2024-12-04 — — EP disclosed
WO-2023146987-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback